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A B S T R A C T  
Objective: To compare the anti-diabetic activity of aqueous extract of stem bark of Berberis lycium Royle and 
Pioglitazone –a thiazolidinedione in a type 2 diabetes mellitus induced male mice model. 
Material and Methods: This Randomized control trial was carried out in the animal house of National Institute of Health 
(NIH), Islamabad for 10 weeks. Fifty albino Balb/C male mice were divided randomly into groups I-V (10 in each group). 
Group I served as normal control group. In rest of the forty mice from group II-V, type 2 diabetes mellitus was induced by 
administration of high fat diet (HFD) for two weeks followed by low dose (40 mg/kg) intra-peritoneal Streptozotocin (STZ) 
injections for four consecutive days. Group II served as the disease control group, group III received the aqueous extract 
of stem bark of Berberis lycium Royle in dose of 50 mg/kg body wt. while group IV received the aqueous extract of stem 
bark of Berberis lycium Royle in dose of 100 mg/kg body wt. Group V was administered Pioglitazone in a dose of 
30mg/kg body wt. The herb extract and the drug was given orally once a day for six consecutive weeks. Samples were 
taken at the end of ten weeks.  
Results: The blood samples estimated for fasting blood glucose (FBG) & glycosylated hemoglobin (HbA1c %) levels 
showed that the aqueous extract of stem bark of Berberis lycium Royle in a high dose (100 mg/kg body wt.) maximally 
lowered the FBG and HbA1c% levels followed by its low dose (50 mg/kg body wt.) Pioglitazone also reduced the FBG 
and HbA1c% to normal limits but its extent was less than the aqueous extract of stem bark of Berberis lycium Royle. 
Conclusion: The aqueous extract of stem bark of Berberis lycium Royle lowers the FBG and HbA1c levels in a type 2 
diabetes induced male mice in a dose dependent manner.  
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I n t r o d u c t i o n  
 
Around the world, Diabetes affects 2-3% of the total 
population. So, Diabetes Mellitus is now a clinical 
syndrome.1 It is characterized by long standing 
hyperglycemia along with the disturbances of 
carbohydrate, fat and protein metabolism due to a defect 
in either insulin secretion, action or both.2 Everyday new 
ORIGINAL ARTICLE 
                           36 JIM DC  2017  36 
researches are taking place to discover more efficacious 
drugs. Thus modern medicine has been famous for its 
efficient role but the side effects have always been a 
grim.3 So the trends have gradually started shifting 
towards the use of natural products.4 Berberis lycium 
Royle (family Berberidaceae) is a famous medicinal herb.5 
It is known as Barberry in English.6 Berberis lycium Royle 
is found in Pakistan, Indian Occupied Kashmir, Bhutan, 
Japan, China, Nepal, United Kingdom, Ireland, Turkey 
and parts of Asia, South America, Southern Argentina, 
Chile and Europe.1,2  In Pakistan, it is abundantly found in 
Margalla Hills.7  It is also distributed in northern areas 
such as Gilgit, Baltistan, Ghizer, Astor, Diamer and Swat, 
Khyber Pakhtunkhwa.8  
Berberis lycium Royle as an anti-diabetic agent has been 
investigated. Studies have been conducted on its different 
parts like the root, stem, leaves, fruit and root bark, both 
in crude and extracted forms. Its stem bark has not been 
investigated yet, despite the fact that the stem bark is 
readily available in local market.  Berberine-the active 
ingredient with the anti-diabetic potential, is present in 
highest concentrations in roots followed by stem bark.9,10 
So far the anti-diabetic activity of Berberis lycium Royle 
has been compared with the current anti-diabetic agents 
like Insulin, Gliclazide, Glibenclamide.10,11 In the present 
study, aqueous extract of stem bark of the herb was 
selected and its anti-diabtic property was compared to 
another oral anti-diabetic drug; Pioglitazone.  
    M a t e r i a l  a n d  M e t h o d s  
A randomized controlled study of ten weeks’ duration was 
carried in the animal house of National Institute of Health 
(NIH), Islamabad. A total of fifty healthy male albino 
Balb/C mice, weighing 28-38g and aged between 6-8 
weeks, having fasting blood glucose (FBG) levels not 
more than 110 mg/dl and HbA1c <6.0 were included in 
study. All mice were acclimatized for one week and then 
they were randomly divided in five groups (group I-V), 
each group containing 10 mice in total. Group I (n=10) 
served as the normal control group. In rest of forty mice 
(group II-V), type 2 diabetes mellitus was induced by 
administration of high fat diet (HFD) for two weeks 
followed by low dose intra-peritoneal injection of freshly 
prepared Streptozotocin (STZ), once daily for four 
consecutive days.12,13 A persistent FBG level >250mg/dl 
was selected as the cut off point for the confirmation of 
Diabetes.14 Group II was the diabetes control group to 
which no drug or herb was given. Group III received 50 
mg/kg body wt. (low dose) of aqueous extract of stem 
bark of Berberis lycium Royle while the group IV received 
100 mg/kg body wt. (high dose) of aqueous extract of 
stem bark of Berberis lycium Royle. The group V received 
the drug; pioglitazone in a dose of 30mg/kg body wt. The 
herb and the drug were given orally once daily for six 
consecutive weeks. Mice were housed under the 
controlled conditions of room temperature 20+2o C, 
relative humidity 50%-70% and 12-h light-dark cycle. 
They were provided free access to water ad libitum. All 
mice were handled in accordance to the NIH guidelines. 
The stem bark of Berberis lycium Royle was collected 
from village Prang, Charsadda. It was identified by a 
botanist at Botany department, Peshawar University. It 
was then washed thoroughly with water and shade dried. 
It was grounded into a fine powder with an electrical 
grinder and taken into a non-metallic jar. The bark powder 
was soaked in distilled water for 72 hours with periodic 
stirring. It was then filtered using Whatmann filter paper 
no.1. The filtrate was evaporated at 55 0C in a rotary 
evaporator at the research laboratory of Riphah Institute 
of Pharmaceutical Sciences (RIPS), Islamabad. The 
extract was obtained as a dark brown semi-solid sticky 
paste. It was stored in air tight glass bottles, protected 
from light and kept in refrigerator at 2-8 oC to be used 
throughout the experiment. The yield of aqueous extract 
of stem bark of Berberis lycium Royle with respect to the 
original dry plant material was about 25%.15 
Blood samples were taken at the end of week 4 for the 
confirmation of diabetes mellitus and at the end of week 
10 for final sampling. The 6-hr fasting blood samples were 
preferred as blood glucose levels vary widely together 
with food intake during a typical day.16-18 Fasting blood 
glucose (FBG) levels were measured using glucose 
oxidase/ GOD POD method1 while glycosylated 
hemoglobin (HbA1C%) of the mice were determined by 
cation exchange resin method.19,20  
Descriptive statistics were applied using one way ANOVA 
test on SPSS 20. The level of significance was pre-
defined as <0.05 (p<0.05).  
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R e s u l t s  
The final blood sampling at the end of week 10 i.e. 
termination of study, showed the following results: 
Significant difference was observed between group II & III 
at the end of week 10, regarding the mean FBG levels 
(457.3+19.6 vs. 87.2+1.8) p<0.05 and mean HbA1c% 
(9.8+0.5 vs. 4.7+0.1) p<0.05 as shown in figure I & II. It 
was thus reported that the low dose (50mg/kg body wt.) of 
aqueous extract of stem bark of Berberis lycium Royle 
significantly decreased the mean FBG and HbA1c levels 
in diabetic mice as compared to disease control group.  
Significant difference was observed between group II & IV 
at the end of week 10 in their mean FBG levels by Kit 
method (457.3+19.6 vs 77.4+2.0) p<0.05 and mean 
HbA1C% of group IV (9.8+0.5 vs 4.4+0.1) p<0.05 as 
shown in figure I & II. Thus, it is observed that the high 
dose (100mg/kg body wt.) of aqueous extract of stem 
bark of Berberis lycium Royle significantly decreased the 
mean FBG and HbA1c levels in diabetic mice as 
compared to disease control group.  
Significant reduction in the mean FBG 
(457.3+19.6vs.96.1+2.4) p<0.05 and HbA1c% levels 
(9.8+0.5vs.5.1+0.1) p<0.05 was observed in group V at 
the end of week 10 in comparison with group II (diabetes 
mellitus control group) as shown in figure I & II.  
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Figure I: Effect of herb extract and drug on FBG(mg/dl) 
levels of group I-V (n=50) 
 
Maximum reduction was observed in high dose group, 
followed by low dose group and then pioglitazone group. 
Statistically difference was insignificant (p>0.05) among 
the group III, IV, V in their FBG and HbA1c levels.  
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Figure 2: Effect of herb extract and herb on HbA1c levels 
(%) of group I-V (n=50) 
D i s c u s s i o n  
Naturopathy is the current trend now.21 In this study, the 
hypoglycemic activity of stem bark of Berberis lycium 
Royle was observed and compared with pioglitazone. The 
results indicated that the aqueous extract of stem bark of 
Berberis lycium Royle has a significant hypoglycemic 
effect (p<0.05), in a dose-dependent manner. FBG levels 
were lowest in the group receiving aqueous extract of 
Berberis lycium Royle stem bark at a dose of 100mg/kg 
body wt. (p=0.00) The levels were even lower than those 
of the normal control. However, statistically insignificant 
difference (p>0.05) was observed among the group III, IV, 
V in their FBG and HbA1c levels. These results correlate 
with the study carried by Gulfraz and Mahmood which 
reported hypoglycemic activity of methanolic extract of 
root of Berberis lycium Royle.10 These results also 
correlate with the study done by Maqsood Ahmed which 
showed the glucose lowering ability of powdered root bark 
of Berberis lycium Royle and its extracts.11 The other 
parameter of the study was the glycosylated hemoglobin 
(HbA1c) levels. The aqueous extract of Berberis lycium 
Royle stem bark also decreased the level of glycosylated 
hemoglobin (HbA1c%) in a dose dependent manner. High 
dose (100mg/kg body wt.) produced marked reduction in 
HbA1c level followed by the low dose (50mg/kg body wt.) 
(p<0.05) These results again are in accordance with the 
work of Gulfraz and Mahmood on the extract of Berberis 
lycium Royle root.10 Pioglitazone also reduced the FBG 
and HbA1C% upto the normal levels but to a lesser extent 
then the herb stem extract. 
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The glucose lowering effect of aqueous extract of stem 
bark of Berberis lycium Royle is probably due to presence 
of an alkaloid- berberine in stem.22 A study by Yin J and 
co-workers in 2002 demonstrated the blood glucose 
lowering activity of berberine was similar to that of 
metformin.23 Another study showed that berberine 
decreases blood glucose levels by increasing glucose 
transport by enhancement of GLUTs.24 Berberine has 
also found to stimulate the activity of AMPK (AMP 
mediated protein kinase) by mitochondrial inhibition and 
thus enhancing the GLUT-4 and GLUT-1 translocations 
resulting in insulin independent mechanism of glucose 
consumption.25 
Further studies are required to investigate the 
pharmacokinetic properties and drug interactions of the 
aqueous extract of stem bark of Berberis lycium Royle so 
that the desired effects produced by the herbal extract 
can be promptly achieved.  
C o n c l u s i o n  
The aqueous extract of stem bark of Berberis lycium 
Royle significantly lowered the fasting blood glucose and 
HbA1c levels in diabetes mellitus type 2 induced male 
mice model in a dose dependent manner. The glucose 
lowering effects of the aqueous extract of stem bark of 
Berberis lycium Royle in type 2 diabetes mellitus induced 
male mice were comparable with the glucose lowering 
effects of Pioglitazone. Although the extent of the glucose 
lowering effects of extract was greater than Pioglitazone.  
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